Drawing from the American Rescue Plan, President Joe Biden’s administration is setting aside more than $3 billion to accelerate the discovery, development and manufacturing of antiviral medicines. The move is part of what the Biden Administration is calling a “whole-of-government” strategy to develop the next generation of COVID-19 treatments.
Biden Administration invests $3 billion from ARP as part of COVID-19 antiviral development strategy
